resTORbio

About:

resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.

Website: https://www.restorbio.com

Twitter/X: twitteer_d

Top Investors: OrbiMed, Fidelity, PureTech Health, Rock Springs Capital, Recharge Capital

Description:

resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.The Company develops medicines and therapies to treat aging-related diseases and conditions such as cancer, heart disease, neurodegenerative diseases, and diabetes mellitus. resTORbio serves clients in the State of Massachusetts.

Total Funding Amount:

$115M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

Remoo2123(AT)hotmail.com

Founders:

Chen Schor, Joan Mannick

Number of Employees:

1-10

Last Funding Date:

2019-03-22

IPO Status:

Public

Industries:

© 2025 bioDAO.ai